Oncotelic Therapeutics Dirección
Dirección controles de criterios 2/4
We currently do not have sufficient information about the CEO.
Información clave
Vuong Trieu
Chief Executive Officer (CEO)
n/a
Compensación total
| Porcentaje del salario del CEO | n/a |
| Permanencia del CEO | 10.8yrs |
| Participación del CEO | 24.5% |
| Permanencia media de la dirección | 5yrs |
| Promedio de permanencia en la Junta Directiva | sin datos |
Actualizaciones recientes de la dirección
Recent updates
Análisis de compensación del CEO
| Fecha | Compensación total | Salario | Ingresos de la empresa |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | -US$1m |
| Mar 31 2024 | n/a | n/a | -US$8m |
| Dec 31 2023 | n/a | n/a | -US$8m |
| Sep 30 2023 | n/a | n/a | -US$12m |
| Jun 30 2023 | n/a | n/a | -US$13m |
| Mar 31 2023 | n/a | n/a | US$9m |
| Dec 31 2022 | US$129k | US$38k | US$5m |
| Sep 30 2022 | n/a | n/a | US$9m |
| Jun 30 2022 | n/a | n/a | US$8m |
| Mar 31 2022 | n/a | n/a | -US$11m |
| Dec 31 2021 | US$257k | US$190k | -US$9m |
| Sep 30 2021 | n/a | n/a | -US$11m |
| Jun 30 2021 | n/a | n/a | -US$11m |
| Mar 31 2021 | n/a | n/a | -US$8m |
| Dec 31 2020 | US$216k | US$169k | -US$10m |
| Sep 30 2020 | n/a | n/a | -US$10m |
| Jun 30 2020 | n/a | n/a | -US$9m |
| Mar 31 2020 | n/a | n/a | -US$10m |
| Dec 31 2019 | US$259k | US$115k | -US$7m |
Compensación vs. Mercado: Insufficient data to establish whether Vuong's total compensation is reasonable compared to companies of similar size in the US market.
Compensación vs. Ingresos: Vuong's compensation has been consistent with company performance over the past year.
CEO
Vuong Trieu (61 yo)
10.8yrs
Permanencia
Dr. Vuong Trieu, Ph.D. serves as the co-founder, President, Chairman and Chief Executive Officer of Oncotelic Inc. Dr. Trieu serves as Chairman and Chief Executive Officer of Oncotelic Therapeutics, Inc (f...
Equipo directivo
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| Chairman & CEO | 10.8yrs | sin datos | 24.47% $ 3.3m | |
| Chief Financial Officer | 5.3yrs | sin datos | 0.088% $ 11.8k | |
| Chief Medical Officer – Translation Medicine & Director | 4.6yrs | sin datos | 0.28% $ 37.5k | |
| CBO & GM of AI Division | 5yrs | sin datos | 4.05% $ 543.1k | |
| Consultant & Director | no data | sin datos | 0% $ 0 | |
| Chief Scientific Officer | no data | sin datos | 5.77% $ 774.0k | |
| Chief Regulatory Officer & Chief Medical Officer | 2.5yrs | sin datos | sin datos | |
| CTO of AI Division | no data | sin datos | sin datos |
5.0yrs
Permanencia media
61yo
Promedio de edad
Equipo directivo experimentado: OTLC's management team is seasoned and experienced (5 years average tenure).